Efficacy of WeChat-Based Digital Intervention Versus Metformin in Women With Polycystic Ovary Syndrome: Randomized Controlled Trial
Open accessPublished version of a preprint
The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index; 24 of the 46 sources its claims cite were checked for support.
Abstract
Background: The first-line treatment for polycystic ovary syndrome (PCOS) is lifestyle modification. However, it is currently unknown whether digital medicine can assist patients with PCOS in maintaining a healthy lifestyle while alleviating PCOS symptoms. Objective: This study aims to evaluate the efficacy of WeChat-based digital intervention versus metformin treatment in women with PCOS and insulin resistance. Methods: A total of 80 women with PCOS and insulin resistance were recruited from an endocrinology clinic and randomly assigned to receive either a WeChat-based digital intervention (n=40, 50%) or metformin (n=40, 50%) for 12 weeks. The WeChat-based digital intervention consisted of 3 modules; a coach assisted the patients in using the intervention. The primary outcome was the change in a homeostatic model assessment for insulin resistance. At baseline and after the 12-week intervention, anthropometric parameters, menstruation frequency, sex hormone levels, metabolic factors, and body fat distribution were measured in the clinic. Furthermore, self-assessed web-based questionnaires on diet, exercise, sleep, anxiety, and depression were obtained. Results: A total of 72 participants completed the follow-up (for a 90% follow-up rate), including 35 of 40 (88%) participants from the digital intervention group and 37 of 40 (93%) participants from the metformin group. The homeostatic model assessment for insulin resistance in the digital intervention group was significantly improved after 12 weeks of treatment with a mean change of –0.93 (95% CI –1.64 to –0.23), but no statistical difference was observed between the groups (least squares mean difference –0.20; 95% CI –0.98 to 0.58; P=.62). Both digital intervention and metformin treatment significantly improved menstruation frequency (digital intervention: P<.001; metformin: P<.001) and reduced body weight (digital intervention: P<.001; metformin: P<.001) and total fat mass (digital intervention: P<.001; metformin: P<.001). Furthermore, the digital intervention had a significant advantage over metformin in improving waist circumference (least squares mean difference –1.84; 95% CI –3.44 to –0.24; P=.03), waist-to-hip ratio (least squares mean difference –0.02; 95% CI –0.03 to 0.00; P=.03), total fat mass (least squares mean difference –1.59; 95% CI –2.88 to –0.30; P=.02), and dehydroepiandrosterone sulfate (least squares mean difference –69.73; 95% CI –129.70 to –9.75; P=.02). In terms of safety, the main adverse events were sensations of hunger in the digital intervention group (2/40, 5%) and gastrointestinal adverse events in the metformin group (12/40, 30%). Conclusions: Our data suggest that digital intervention is an effective treatment option for patients with PCOS, with an efficacy comparable to that of metformin, and that it can also alleviate the negative effects of medications and make it easier and more efficient to adhere to lifestyle treatments. WeChat-based digital interventions have the potential to provide a new path for the improvement and health of women with PCOS in China. Trial Registration: ClinicalTrials.gov NCT05386706; https://clinicaltrials.gov/study/NCT05386706
Overview
CoChat Summary
TL;DR
In a 12-week randomized trial of 80 women with PCOS and insulin resistance, a WeChat-based digital lifestyle intervention was not statistically different from metformin for improving HOMA-IR, but it produced greater reductions in waist circumference, waist-to-hip ratio, total fat mass, and DHEAS. The digital intervention also had fewer adverse events than metformin, though metformin adherence was higher.
Key findings
- HOMA-IR improved significantly within the digital intervention group (mean change –0.93, 95% CI –1.64 to –0.23) and the metformin group (–1.07, 95% CI –2.04 to –0.09), with no significant between-group difference (least squares mean difference –0.20; 95% CI –0.98 to 0.58; P=.62).
- Both groups significantly improved menstruation frequency (both P<.001), body weight (both P<.001), and total fat mass (both P<.001); between-group differences were not significant for menstruation frequency (P=.91) or weight (P=.63).
- The digital intervention had a significant advantage over metformin for waist circumference (least squares mean difference –1.84 cm; 95% CI –3.44 to –0.24; P=.03), waist-to-hip ratio (–0.02; 95% CI –0.03 to 0.00; P=.03), total fat mass (–1.59 kg; 95% CI –2.88 to –0.30; P=.02), and DHEAS (–69.73 μg/dL; 95% CI –129.70 to –9.75; P=.02).
- Adverse events were less frequent with digital intervention: sensations of hunger in 2/40 (5%) and dizziness in 1/40 (3%), versus gastrointestinal adverse events in 12/40 (30%) with metformin; metformin discontinuation due to adverse events was 5% (2/40).
Methods
- Single-center, unblinded, 2-arm parallel randomized controlled trial with 1:1 allocation; 80 women with PCOS and HOMA-IR ≥1.8 were recruited from an endocrinology clinic at a tertiary affiliated hospital of Tongji University between June 21, 2022, and August 12, 2023.
- Participants received either a WeChat-based digital intervention (n=40) with 3 modules and coach support or metformin 1000 mg/day (n=40) for 12 weeks; primary outcome was change in HOMA-IR, with clinical, laboratory, body composition, and questionnaire measures at baseline and 12 weeks.
- Analysis used intention-to-treat with SPSS version 25; continuous outcomes were analyzed with ANCOVA using treatment as a fixed effect and baseline value as covariate, with P<.05 considered significant.
Limitations
- Stated by the authors: the sample was limited to insulin-resistant PCOS and does not represent all PCOS; sex hormones were not monitored during menstruation; participants were not blinded and multiple evaluations increased type 1 error risk; no formal cost evaluation was conducted; and long-term follow-up data are lacking.
- Evident from the text: the trial was single-center, relatively small (80 randomized, 72 followed up), and short-term (12 weeks), limiting generalizability and durability assessment.
- Evident from the text: adherence was lower in the digital intervention group (89%, 95% CI 83%-95%) than in the metformin group (98%, 95% CI 96%-99%; P=.003), and the exclusion of perimenopausal or menopausal women was a protocol deviation not reported in the ClinicalTrials.gov registration.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
17 Valid · 2 Not valid · 13 Not checked · 126 Own results and interpretations
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“Our power analysis revealed that according to a web-based calculator (MedSci Sample Size tools), with a 30% sample loss rate, a minimum of 30 participants were required for each group to achieve a significant outcome (α=.05, power=0.90); the total sample size of the study was 60.”
§ Efficacy of WeChat-Based Digital Intervention Versus Metformin in Women With Polycystic Ovary Syndrome: Randomized Controlled Trial > Methods > Measurements
What the sources say
- Not checked — no full text of the sourcecites [17] source
- Not checked — no full text of the sourcecites [25] source
- Disputedcites [26] sourceExperimental — accuracy not yet measured
The Statistical analysis section reports a different sample-size calculation: 20% anticipated dropout, 80% power, and 114 participants per group across three groups (342 total). Although both use α = .05, the cited paper does not report 30% loss, 90% power, or 30 participants per group. (LLM, conf=0.95)
Checked by a reasoning model — may be wrong.
plainn = 30- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Every source the paper cites for this claim was checked and supports it.
In the paper
“In a recent study, anthropometric indicators, including body weight, waist circumference, and fat mass, significantly improved in the web-based lifestyle intervention group compared with the control group [33].”
§ Efficacy of WeChat-Based Digital Intervention Versus Metformin in Women With Polycystic Ovary Syndrome: Randomized Controlled Trial > Discussion > Principal Findings
What the sources say
- Supportedcites [33] source
The Abstract Results report significant improvements in body weight, waist circumference, and fat mass in the intervention group compared with the control group. The Results section, “Body Weight and Body Composition,” also reports greater weight and fat-mass loss and a greater long-term decrease in waist circumference. (LLM, conf=0.95)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Similarly, previous research showed that metformin did not significantly reduce waist circumference as much as lifestyle change did [31,32].”
§ Efficacy of WeChat-Based Digital Intervention Versus Metformin in Women With Polycystic Ovary Syndrome: Randomized Controlled Trial > Discussion > Principal Findings
What the sources say
- Supportedcites [31] source
The Results report that waist circumference after treatment was significantly lower in the lifestyle-modification group than in the other three groups, including the metformin group (P=.001). This supports the comparative claim for the women with PCOS studied. (LLM, conf=0.92)
- Not checked — no full text of the sourcecites [32] source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“In previous studies, both insulin resistance status improvement and circulating insulin reduction have been shown to increase serum SHBG levels, thereby reducing the blood level of free testosterone in patients with PCOS [34,42].”
§ Efficacy of WeChat-Based Digital Intervention Versus Metformin in Women With Polycystic Ovary Syndrome: Randomized Controlled Trial > Discussion > Principal Findings
What the sources say
- Supportedcites [34] source
The Discussion states that decreased circulating insulin and improved insulin resistance can increase serum SHBG, leading to decreased free testosterone in patients with PCOS. This directly supports the attributed claim. (LLM, conf=0.94)
- Supportedcites [42] source
The Discussion (page not supplied) states that insulin resistance and hyperinsulinemia in women with PCOS lower SHBG and raise free testosterone, and that insulin restrains SHBG production. It also reports improved insulin resistance, increased SHBG, and decreased free testosterone after the study intervention, consistent with the claim. (LLM, conf=0.86)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“After the 12-week intervention, both groups exhibited substantial improvements in body measurements, including body weight, BMI, waist circumference, hip circumference, and waist-to-hip ratio.”
§ Efficacy of WeChat-Based Digital Intervention Versus Metformin in Women With Polycystic Ovary Syndrome: Randomized Controlled Trial > Results > Overall Intervention Effect Between Groups
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
74 more claims
Create a free account to see all 158 claims and every source verdict.
- Probably not a substantial claim. 44
- It may state two separate claims as one. 44
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Apps can be a feasible means to deliver a PCOS-specific lifestyle intervention [29303435]”
From Availability and Use of Digital Technology Among Women With Polycystic Ovary Syndrome: Scoping Review (2025) · cites this paper as [34]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
“Homeostatic model assessment of insulin resistance | –0.93 (–1.64 to –0.23) | –1.07 (–2.04 to –0.09) | –0.20 (–0.98 to 0.58)”
§ Efficacy of WeChat-Based Digital Intervention Versus Metformin in Women With Polycystic Ovary Syndrome: Randomized Controlled Trial > Results > Overall Intervention Effect Between Groups
Reported -0.2 · recomputed 0.14
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“Pittsburgh Sleep Quality Index score | 6.35 (5.08-7.02) | 6.05 (5.46-7.24)”
§ Efficacy of WeChat-Based Digital Intervention Versus Metformin in Women With Polycystic Ovary Syndrome: Randomized Controlled Trial > Results > Participant Characteristics
Reported 6.05 · recomputed 6.35
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“Pittsburgh Sleep Quality Index score | 6.35 (5.08-7.02)”
§ Efficacy of WeChat-Based Digital Intervention Versus Metformin in Women With Polycystic Ovary Syndrome: Randomized Controlled Trial > Results > Participant Characteristics
Reported 6.35 · recomputed 6.05
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Efficacy of WeChat-Based Digital Intervention Versus Metformin in Women With Polycystic Ovary Syndrome: Randomized Controlled Trial > Methods > Study Design and Participants
“were enrolled between June 21, 2022, and August 12, 2023”
§ Efficacy of WeChat-Based Digital Intervention Versus Metformin in Women With Polycystic Ovary Syndrome: Randomized Controlled Trial > Results > Participant Characteristics
“The process of recruiting ran from June 2022 to May 2023”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Efficacy of WeChat-Based Digital Intervention Versus Metformin in Women With Polycystic Ovary Syndrome: Randomized Controlled Trial > Methods > Study Design and Participants
“were enrolled between June 21, 2022, and August 12, 2023”
§ Efficacy of WeChat-Based Digital Intervention Versus Metformin in Women With Polycystic Ovary Syndrome: Randomized Controlled Trial > Results > Participant Characteristics
“the follow-up assessments were completed in August 2023”
Citations
Cites
The Hospital Anxiety and Depression Scale
Zigmond, A. S., & Snaith, R. P. (1983) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1983.tb09716.x · Cited by 47,139 · cited 1×
“A 14-item test called the HADS is used to assess an individual’s anxiety and depression levels [24].”
The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research
Buysse, D. J., Reynolds, C. F., Monk, T. H., Berman, S. R., & Kupfer, D. J. (1989) · Psychiatry Research · doi:10.1016/0165-1781(89)90047-4 · Cited by 35,234 · cited 1×
“The PSQI is a self-report assessment tool that measures sleep quality over a 30-day period [23].”
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502 · cited 1×
“(Fasting blood glucose [mmol/L]×fasting insulin [mU/L])/22.5 was used to calculate the HOMA-IR levels [19].”
InfluentialToprak, O., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney and Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,627
International physical activity questionnaire: 12-country reliability and validity
CRAIG, C. L., MARSHALL, A. L., SJ??STR??M, M., BAUMAN, A. E., BOOTH, M. L., AINSWORTH, B. E., PRATT, M., EKELUND, U., YNGVE, A., SALLIS, J. F., et al. (2003) · Medicine & Science in Sports & Exercise · doi:10.1249/01.mss.0000078924.61453.fb · Cited by 21,619 · cited 1×
“It provides data on the amount of time spent each week on several physical activity domains, including low, moderate, and vigorous intensity [21,22].”
Depression and quality of life in older persons: A review
Sivertsen, H., Bjørkløf, G. H., Engedal, K., Selbæk, G., & Helvik, A.-S. (2015) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000437299 · Cited by 14,152
(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050
Polycystic Ovary Syndrome: Definition, Aetiology, Diagnosis and Treatment
Escobar-Morreale, H. F. (2018) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2018.24 · Cited by 2,083 · cited 1×
“The PCOS guidelines recommend lifestyle interventions as the first-line treatment for PCOS (diet, exercise, sleep, and mood) [12,13].”
Criteria, Prevalence, and Phenotypes of Polycystic Ovary Syndrome
Lizneva, D., Suturina, L., Walker, W., Brakta, S., Gavrilova-Jordan, L., & Azziz, R. (2016) · Fertility and Sterility · doi:10.1016/j.fertnstert.2016.05.003 · Cited by 1,358 · cited 1×
“PCOS is characterized by a range of heterogeneous symptoms with varying severities, including abnormal menstruation, hyperandrogenism (hirsutism or hyperandrogenemia), and ovarian dysfunction (oligo-ovulation or polycystic ovary morphology) [2].”
Karlsson, J., Persson, L.-O., Sjöström, L., & Sullivan, M. (2000) · International Journal of Obesity · doi:10.1038/sj.ijo.0801442 · Cited by 1,104 · cited 1×
“TFEQ-R21 is a questionnaire used to examine eating behavior [20].”
Healthcare in the pocket: Mapping the space of mobile-phone health interventions
Klasnja, P., & Pratt, W. (2012) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2011.08.017 · Cited by 970
Tang, T., Lord, J. M., Norman, R. J., Yasmin, E., & Balen, A. H. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003053.pub5 · Cited by 698
Teede, H. J., Tay, C. T., Laven, J., Dokras, A., Moran, L. J., Piltonen, T. T., Costello, M. F., Boivin, J., M. Redman, L., A. Boyle, J., et al. (2023) · Fertility and Sterility · doi:10.1016/j.fertnstert.2023.07.025 · Cited by 417 · cited 1×
“Approximately 10% to 13% of women of reproductive age worldwide have polycystic ovary syndrome (PCOS) [1].”
Zhao, H., Zhang, J., Cheng, X., Nie, X., & He, B. (2023) · Journal of Ovarian Research · doi:10.1186/s13048-022-01091-0 · Cited by 408 · cited 1×
“For such patients, insulin resistance reduction is essential in the management of various endocrine and metabolic disorders [4].”
Morley, L. C., Tang, T., Yasmin, E., Norman, R. J., & Balen, A. H. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003053.pub6 · Cited by 296
Han, Y.-C., Tang, S.-Q., Liu, Y.-T., Li, A.-M., Zhan, M., Yang, M., Song, N., Zhang, W., Wu, X.-Q., Peng, C.-H., et al. (2021) · Cell Death & Disease · doi:10.1038/s41419-021-04184-8 · Cited by 257 · cited 1×
“Consistently, metformin decreased the serum creatinine levels and renal oxidative damage and fibrosis in a study on diabetic mice [39].”
Esteghamati, A., Ashraf, H., Khalilzadeh, O., Zandieh, A., Nakhjavani, M., Rashidi, A., Haghazali, M., & Asgari, F. (2010) · Nutrition & Metabolism · doi:10.1186/1743-7075-7-26 · Cited by 212 · cited 1×
“…criteria were being aged 18 to 45 years, having a clinical diagnosis of PCOS according to the 2003 Rotterdam diagnostic criteria [10], and having a HOMA-IR score ≥ 1.8 (in Asian countries, a HOMA-IR score ≥ 1.8 can diagnose insulin resistance and predict the occurrence of metabolic syndrome [11]).”
InfluentialInsulin resistance and PCOS: chicken or egg?
Moghetti, P., & Tosi, F. (2021) · Journal of Endocrinological Investigation · doi:10.1007/s40618-020-01351-0 · Cited by 209 · cited 1×
“Using gold standard procedures, it was estimated that approximately 75% of patients with PCOS had insulin resistance and that the endocrine and reproductive characteristics of PCOS can be brought on by insulin resistance [27].”
Løvvik, T. S., Carlsen, S. M., Salvesen, Ø., Steffensen, B., Bixo, M., Gómez-Real, F., Lønnebotn, M., Hestvold, K. V., Zabielska, R., Hirschberg, A. L., et al. (2019) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(19)30002-6 · Cited by 176 · cited 1×
“In previous clinical trials, the dose of metformin ranged from 850 mg to 2000 mg per day [18].”
Tong, C., Wu, Y., Zhang, L., & Yu, Y. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1091147 · Cited by 157 · cited 1×
“One of the most prevalent endocrine disorders among patients with PCOS is insulin resistance, with variable degrees of insulin resistance present in approximately 75% of patients with PCOS [3].”
Yilmaz, M., Bukan, N., Ayvaz, G., Karakoç, A., Törüner, F., Çakir, N., & Arslan, M. (2005) · Human Reproduction · doi:10.1093/humrep/dei258 · Cited by 138
Fitzsimmons-Craft, E. E., Taylor, C. B., Graham, A. K., Sadeh-Sharvit, S., Balantekin, K. N., Eichen, D. M., Monterubio, G. E., Goel, N. J., Flatt, R. E., Karam, A. M., et al. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.15633 · Cited by 125
Al Wattar, B. H., Fisher, M., Bevington, L., Talaulikar, V., Davies, M., Conway, G., & Yasmin, E. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab232 · Cited by 123 · cited 1×
“The PCOS guidelines recommend lifestyle interventions as the first-line treatment for PCOS (diet, exercise, sleep, and mood) [12,13].”
Karimzadeh, M. A., & Javedani, M. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2009.02.078 · Cited by 118 · cited 1×
“Similarly, previous research showed that metformin did not significantly reduce waist circumference as much as lifestyle change did [31,32].”
Schriock, E. D., Buffington, C. K., Hubert, G. D., Kurtz, B. R., Kitabchi, A. E., Buster, J. E., & Givens, J. R. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-66-6-1329 · Cited by 115 · cited 1×
“As metformin can improve insulin sensitivity and adrenal cells have insulin receptors [41], insulin may have an impact on peripheral or adrenal tissue DHEAS metabolism.”
Papathanasiou, G., Georgoudis, G., Georgakopoulos, D., Katsouras, C., Kalfakakou, V., & Evangelou, A. (2010) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/hjr.0b013e328333ede6 · Cited by 111 · cited 1×
“It provides data on the amount of time spent each week on several physical activity domains, including low, moderate, and vigorous intensity [21,22].”
The use of berberine for women with polycystic ovary syndrome undergoing IVF treatment
An, Y., Sun, Z., Zhang, Y., Liu, B., Guan, Y., & Lu, M. (2014) · Clinical Endocrinology · doi:10.1111/cen.12294 · Cited by 105 · cited 1×
“Multiple studies have shown that alleviating insulin resistance is closely associated with improving menstrual cycles, ovulation, and in vitro fertilization results in PCOS [28-30].”
Self-citationWen, Q., Hu, M., Lai, M., Li, J., Hu, Z., Quan, K., Liu, J., Liu, H., Meng, Y., Wang, S., et al. (2022) · Human Reproduction · doi:10.1093/humrep/deab272 · Cited by 93 · cited 2×
“Prior research has shown that when several therapy methods (such as metformin, rosiglitazone, and acupuncture) were given for approximately 12 weeks, patients with PCOS experienced improvements in their hyperandrogenemia, weight loss, and metabolic and biochemical parameters [17,25,26].”
InfluentialSelf-citationCarl, J. R., Miller, C. B., Henry, A. L., Davis, M. L., Stott, R., Smits, J. A. J., Emsley, R., Gu, J., Shin, O., Otto, M. W., et al. (2020) · Depression and Anxiety · doi:10.1002/da.23079 · Cited by 86 · cited 1×
“In a recent study of digital intervention for other diseases, it effectively improved physical activity, depression, anxiety, and eating behavior [45-47].”
Effects of a Digital Diabetes Prevention Program: An RCT
Katula, J. A., Dressler, E. V., Kittel, C. A., Harvin, L. N., Almeida, F. A., Wilson, K. E., Michaud, T. L., Porter, G. C., Brito, F. A., Goessl, C. L., et al. (2022) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2021.10.023 · Cited by 86 · cited 1×
“Alternatively, the digital intervention significantly reduced the HbA 1c levels in patients with prediabetes and diabetes [35,36].”
Lugones-Sanchez, C., Recio-Rodriguez, J. I., Agudo-Conde, C., Repiso-Gento, I., G Adalia, E., Ramirez-Manent, J. I., Sanchez-Calavera, M. A., Rodriguez-Sanchez, E., Gomez-Marcos, M. A., Garcia-Ortiz, L., et al. (2022) · Journal of Medical Internet Research · doi:10.2196/30416 · Cited by 85
Moran, L. J., Tassone, E. C., Boyle, J., Brennan, L., Harrison, C. L., Hirschberg, A. L., Lim, S., Marsh, K., Misso, M. L., Redman, L., et al. (2020) · Obesity Reviews · doi:10.1111/obr.13046 · Cited by 84 · cited 1×
“The first-line treatment for PCOS is lifestyle intervention, and studies have demonstrated that positive lifestyle changes can improve hyperandrogenemia, menstrual cycle, hirsutism, and insulin resistance in the affected patients [5].”
Xing, C., Zhao, H., Zhang, J., & He, B. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.945609 · Cited by 82 · cited 2×
“Another study demonstrated that metformin therapy improved anthropometric parameters, menstrual cycles, and glucose metabolism [34].”
Ortega-González, C., Cardoza, L., Coutiño, B., Hidalgo, R., Arteaga‐Troncoso, G., & Parra, A. (2005) · Journal of Endocrinology · doi:10.1677/joe.1.05844 · Cited by 82
Yilmaz, M., Biri, A., Karakoç, A., Törüner, F., Bingöl, B., Çakir, N., Tiras, B., Ayvaz, G., & Arslan, M. (2005) · Journal of Endocrinological Investigation · doi:10.1007/bf03345339 · Cited by 77 · cited 1×
“Multiple studies have shown that alleviating insulin resistance is closely associated with improving menstrual cycles, ovulation, and in vitro fertilization results in PCOS [28-30].”
Jiskoot, G., Dietz de Loos, A., Beerthuizen, A., Timman, R., Busschbach, J., & Laven, J. (2020) · PLOS ONE · doi:10.1371/journal.pone.0233876 · Cited by 76 · cited 2×
“Prior studies evaluated the effectiveness of 20 cognitive behavioral therapy lifestyle courses with physical therapy, healthy eating, and 9 months of extra feedback via a mobile SMS text messaging service to conventional treatment [8].”
Zhang, J., Xing, C., Cheng, X., & He, B. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1003238 · Cited by 73
Liu, F., Song, T., Yu, P., Deng, N., Guan, Y., Yang, Y., & Ma, Y. (2023) · Journal of Medical Internet Research · doi:10.2196/43809 · Cited by 72 · cited 1×
“…therapy accessed on mobile phones, which are convenient and accessible, can effectively improve behavioral changes in diet, exercise, and medication adherence while predicting disease progression, reducing the frequency of disease-related symptoms, and promoting effective disease management [6,7].”
Metformin versus lifestyle changes in treating women with polycystic ovary syndrome
Curi, D. D. G., Fonseca, A. M., Marcondes, J. A. M., Almeida, J. A. M., Bagnoli, V. R., Soares, J. M., & Baracat, E. C. (2012) · Gynecological Endocrinology · doi:10.3109/09513590.2011.583957 · Cited by 60 · cited 2×
“Similarly, previous research showed that metformin did not significantly reduce waist circumference as much as lifestyle change did [31,32].”
Haqq, L., McFarlane, J., Dieberg, G., & Smart, N. (2015) · International Journal of Sport Nutrition and Exercise Metabolism · doi:10.1123/ijsnem.2013-0232 · Cited by 48 · cited 1×
“Similar to our results, a meta-analysis suggests that lifestyle interventions are the best way to improve body composition and cardiorespiratory health in women with PCOS [44].”
Present and Future of Digital Health in Diabetes and Metabolic Disease
Rhee, S. Y., Kim, C., Shin, D. W., & Steinhubl, S. R. (2020) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2020.0088 · Cited by 47
Evidence-based practice in cognitive–behavioural therapy
Stallard, P. (2022) · Archives of Disease in Childhood · doi:10.1136/archdischild-2020-321249 · Cited by 46 · cited 1×
“Cognitive behavioral therapy is a type of treatment that combines behavioral and cognitive methods [14].”
Zhu, S., Li, Z., Hu, C., Sun, F., Wang, C., Yuan, H., & Li, Y. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.697223 · Cited by 41 · cited 1×
“Because central obesity is frequently associated with patients with PCOS [43], we examined the distribution of body fat in these patients.”
Hsia, J., Guthrie, N. L., Lupinacci, P., Gubbi, A., Denham, D., Berman, M. A., & Bonaca, M. P. (2022) · Diabetes Care · doi:10.2337/dc22-1099 · Cited by 41 · cited 1×
“Alternatively, the digital intervention significantly reduced the HbA 1c levels in patients with prediabetes and diabetes [35,36].”
Zhang, D., Yang, X., Li, J., Yu, J., & Wu, X. (2019) · Clinical Endocrinology · doi:10.1111/cen.14050 · Cited by 40
Samadi, Z., Bambaeichi, E., Valiani, M., & Shahshahan, Z. (2019) · International Journal of Preventive Medicine · doi:10.4103/ijpvm.ijpvm_360_18 · Cited by 38 · cited 1×
“In previous studies, both insulin resistance status improvement and circulating insulin reduction have been shown to increase serum SHBG levels, thereby reducing the blood level of free testosterone in patients with PCOS [34,42].”
Moravcová, K., Karbanová, M., Bretschneider, M. P., Sovová, M., Ožana, J., & Sovová, E. (2022) · Nutrients · doi:10.3390/nu14102005 · Cited by 37 · cited 1×
“…study of digital intervention in patients with obesity, the intervention group exhibited significant improvements in HbA 1c , fasting blood glucose, and HOMA-IR levels while retaining muscle mass and reducing body fat and obtained equivalent outcomes to an intensive obesity management program [37].”
Kajbaf, F., Fendri, S., Basille‐Fantinato, A., Diouf, M., Rose, D., Jounieaux, V., & Lalau, J. ‐. (2014) · Diabetic Medicine · doi:10.1111/dme.12362 · Cited by 29 · cited 1×
“Studies have demonstrated that in people with type 2 diabetes, metformin therapy improved sleep quality [48].”
Kohl, J., Brame, J., Centner, C., Wurst, R., Fuchs, R., Sehlbrede, M., Tinsel, I., Maiwald, P., Fichtner, U. A., Armbruster, C., et al. (2023) · Journal of Medical Internet Research · doi:10.2196/43426 · Cited by 29 · cited 1×
“In a recent study, anthropometric indicators, including body weight, waist circumference, and fat mass, significantly improved in the web-based lifestyle intervention group compared with the control group [33].”
Current Perspectives on Nonalcoholic Fatty Liver Disease in Women with Polycystic Ovary Syndrome
Wang, D., & He, B. (2022) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s362424 · Cited by 28 · cited 1×
“Previous studies have shown that nonalcoholic fatty liver disease and liver function in patients with PCOS could be improved by diet control and exercise [38], and patients in the digital intervention group probably changed their diet and exercise routines because of these benefits in our study.”
Zhang, Y.-M., Zong, H.-C., Qi, Y.-B., Chang, L.-L., Gao, Y.-N., Zhou, T., Yin, T., Liu, M., Pan, K.-J., Chen, W.-G., et al. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02283-w · Cited by 27 · cited 1×
“In addition, it reduced social stress–related anxiety-like behaviors [49].”
Self-citationSahu, A., Tripathy, P., Mohanty, J., & Nagy, A. C. (2018) · Journal of Gynecology Obstetrics and Human Reproduction · doi:10.1016/j.jogoh.2018.10.006 · Cited by 24
Jiskoot, G., de Loos, A. D., Timman, R., Beerthuizen, A., Laven, J., & Busschbach, J. (2022) · Journal of Eating Disorders · doi:10.1186/s40337-022-00593-y · Cited by 23 · cited 1×
“…3-component lifestyle intervention consisting of diet, exercise, and cognitive behavioral therapy, facilitated using texting to track patients’ food intake, physical activity, and mood, can effectively improve eating disorder and mood in patients with PCOS and contribute to weight loss [8,9].”
Kjøtrød, S. B., Sunde, A., von Düring, V., & Carlsen, S. M. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2007.11.069 · Cited by 22 · cited 1×
“Metformin therapy has been previously reported to increase DHEAS levels in women with infertility due to PCOS [40].”
Melin, J. M., Forslund, M., Alesi, S. J., Piltonen, T., Romualdi, D., Spritzer, P. M., Tay, C. T., Pena, A. S., Witchel, S. F., Mousa, A., et al. (2024) · Clinical Endocrinology · doi:10.1111/cen.14983 · Cited by 16 · cited 1×
“Metformin, which improves ovulation and enhances insulin sensitivity, is the first-line insulin-sensitizing medication used to treat PCOS; it was used as a treatment drug in the control group in this study [15].”
Sathyapalan, T., Cho, L. W., Kilpatrick, E. S., Coady, A., & Atkin, S. L. (2009) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03345.x · Cited by 11 · cited 3×
“Metformin should be used for at least 3 months after completion depending on the patient’s ovulation recovery, androgen status, and metabolic clinical indicators [16,17].”
InfluentialSalunkhe, V. A., Sinha, N., Ahlqvist, E., Prasad, R. B., Johansson, S., Abrahamsson, B., & Rosengren, A. H. (2023) · npj Digital Medicine · doi:10.1038/s41746-023-00946-0 · Cited by 9 · cited 1×
“In a recent study of digital intervention for other diseases, it effectively improved physical activity, depression, anxiety, and eating behavior [45-47].”
Cited by
Wright, P. J., Burts, C., Harmon, C., & Corbett, C. F. (2025) · JMIR Infodemiology · doi:10.2196/68469 · Cited by 8
“Apps can be a feasible means to deliver a PCOS-specific lifestyle intervention [29,30,34,35].”
Pan, Y., Tang, J., Lu, B., Kuang, M., Zhao, M., Liu, H., & Zhong, S. (2025) · Journal of Medical Internet Research · doi:10.2196/71075 · Cited by 9
“Digital CBT has been proposed as a promising tool for enhancing chronic disease management, with mounting evidence supporting its effectiveness in promoting health-related behavioral modifications [25-28].”
Self-citationTang, J., Song, T., Kuang, M., & Liu, H. (2025) · Therapeutic Advances in Chronic Disease · doi:10.1177/20406223251334439 · Cited by 6
Self-citationYu, B., Li, Y., Ma, C., Reinhardt, J. D., Dou, Q., Zuo, H., Yang, X., Li, M., Cai, C., Fan, Y., et al. (2025) · BMC Medicine · doi:10.1186/s12916-025-04135-6 · Cited by 9
Zeng, H., Dou, Z., Zhang, Y.-N., Wang, C.-C., Xia, T., & Xu, J. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1676915 · Cited by 4
Self-citation
Metadata
- Authors
- Dilimulati, D., Shao, X., Wang, L., Cai, M., Zhang, Y., Lu, J., Wang, Y., Liu, H., Kuang, M., Chen, H., Zhang, M., & Qu, S.
- Affiliations
- Tongji University (CN)
- Shanghai Jiao Tong University (CN)
- Corresponding author
- Zhang, Manna
- ORCID
- Venue
- Journal of Medical Internet Research
- Publisher
- JMIR Publications Inc.
- Published
- 2024-10-02
- Volume
- 26
- Pages
- e55883
- ISSN
- 1438-8871 (ISSN-L)
- PMC
- PMC11483258
- OpenAlex
- W4403052591
- Cited by
- 17
- References
- 52
- Citations by year
- 2026: 9 · 2025: 8
- FWCI
- 6.66
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- Journal of Medical Internet Research (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- National Natural Science Foundation of China (82170861, 81970677, 81601269)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Health Professions › General Health Professions › Mobile Health and mHealth Applications
- Social Sciences › Psychology › Applied Psychology › Digital Mental Health Interventions
- Keywords
- polycystic ovary syndrome, metformin, insulin resistance, lifestyle modification, menstrual frequency, body weight, waist circumference, fat mass, sex hormones, anxiety and depression, mobile health, digital medicine, HOMA-IR, body fat distribution, sleep, physical activity, diet, hirsutism
- MeSH terms
- Adult, Female, Humans, Hypoglycemic Agents, Insulin Resistance, Metformin, Polycystic Ovary Syndrome, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.

